Alaunos Therapeutics, Inc. (TCRT) Tops Q3 EPS by 1c

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Morgan Stanley Starts Target Hospitality (TH) at Overweight
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week